Dapagliflozin (Farxiga)

Drug / Medication

The first SGLT2 inhibitor brought to market, whose development was influenced by Dr. DeFronzo's early work on phlorizin. Shown to lower glucose, improve insulin sensitivity, and beta cell function.

Mentioned in 1 video

Videos Mentioning Dapagliflozin (Farxiga)

337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more

Peter Attia MD

The first SGLT2 inhibitor brought to market, whose development was influenced by Dr. DeFronzo's early work on phlorizin. Shown to lower glucose, improve insulin sensitivity, and beta cell function.